Steven Sherman's most recent trade in Ekso Bionics Holdings Inc was a trade of 91,241 Common Stock done . Disclosure was reported to the exchange on June 8, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ekso Bionics Holdings Inc | Steven Sherman | Executive Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 91,241 | 456,154 (0%) | 0% | 0 | Common Stock | |
| Ekso Bionics Holdings Inc | Steven Sherman | Executive Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 84,240 | 449,153 (0%) | 0% | 0 | Common Stock | |
| Ekso Bionics Holdings Inc | Steven Sherman | Executive Chair | Sale of securities on an exchange or to another person at price $ 1.44 per share. | 24 May 2023 | 45,660 | 364,913 (0%) | 0% | 1.4 | 65,874 | Common Stock |
| Ekso Bionics Holdings Inc | Steven Sherman | Director, Executive Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2022 | 242,679 | 971,343 (1%) | 0% | 0 | Common Stock | |
| Ekso Bionics Holdings Inc | Steven Sherman | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Dec 2022 | 31,198 | 0 | - | - | Restricted Stock Units | |
| Ekso Bionics Holdings Inc | Steven Sherman | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Dec 2022 | 31,198 | 739,240 (0%) | 0% | 0 | Common Stock | |
| Ekso Bionics Holdings Inc | Steven Sherman | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 1.28 per share. | 04 Dec 2022 | 10,576 | 728,664 (0%) | 0% | 1.3 | 13,492 | Common Stock |
| Ekso Bionics Holdings Inc | Steven Sherman | Director, CEO & Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2022 | 15,599 | 31,199 | - | - | Restricted Stock Units | |
| Ekso Bionics Holdings Inc | Steven Sherman | Director, CEO & Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2022 | 15,599 | 713,829 (0%) | 0% | 0 | Common Stock | |
| Ekso Bionics Holdings Inc | Steven Sherman | Director, CEO & Chairman | Sale of securities on an exchange or to another person at price $ 1.26 per share. | 21 Nov 2022 | 5,787 | 708,042 (0%) | 0% | 1.3 | 7,312 | Common Stock |
| Ekso Bionics Holdings Inc | Steven Sherman | Director, CEO & Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Oct 2022 | 15,600 | 46,798 | - | - | Restricted Stock Units | |
| Ekso Bionics Holdings Inc | Steven Sherman | Director, CEO & Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Oct 2022 | 15,600 | 704,151 (0%) | 0% | 0 | Common Stock | |
| Ekso Bionics Holdings Inc | Steven Sherman | Director, CEO & Chairman | Sale of securities on an exchange or to another person at price $ 1.29 per share. | 21 Oct 2022 | 5,921 | 698,230 (0%) | 0% | 1.3 | 7,619 | Common Stock |
| Ekso Bionics Holdings Inc | Steven Sherman | Director, CEO & Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Sep 2022 | 15,599 | 694,594 (0%) | 0% | 0 | Common Stock | |
| Ekso Bionics Holdings Inc | Steven Sherman | Director, CEO & Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Sep 2022 | 15,599 | 62,398 | - | - | Restricted Stock Units | |
| Ekso Bionics Holdings Inc | Steven Sherman | Director, CEO & Chairman | Sale of securities on an exchange or to another person at price $ 1.75 per share. | 21 Sep 2022 | 6,043 | 688,551 (0%) | 0% | 1.7 | 10,553 | Common Stock |
| Ekso Bionics Holdings Inc | Steven Sherman | Director, CEO & Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Aug 2022 | 15,599 | 684,567 (0%) | 0% | 0 | Common Stock | |
| Ekso Bionics Holdings Inc | Steven Sherman | Director, CEO & Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Aug 2022 | 15,599 | 77,997 | - | - | Restricted Stock Units | |
| Ekso Bionics Holdings Inc | Steven Sherman | Director, CEO & Chairman | Sale of securities on an exchange or to another person at price $ 2.20 per share. | 21 Aug 2022 | 5,572 | 678,995 (0%) | 0% | 2.2 | 12,278 | Common Stock |
| Ekso Bionics Holdings Inc | Steven Sherman | Director, CEO & Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jul 2022 | 15,599 | 674,630 (0%) | 0% | 0 | Common Stock | |
| Ekso Bionics Holdings Inc | Steven Sherman | Director, CEO & Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jul 2022 | 15,599 | 93,596 | - | - | Restricted Stock Units | |
| Ekso Bionics Holdings Inc | Steven Sherman | Director, CEO & Chairman | Sale of securities on an exchange or to another person at price $ 1.75 per share. | 21 Jul 2022 | 5,662 | 668,968 (0%) | 0% | 1.8 | 9,909 | Common Stock |
| Ekso Bionics Holdings Inc | Steven Sherman | Director, CEO & Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2022 | 15,599 | 664,361 (0%) | 0% | 0 | Common Stock | |
| Ekso Bionics Holdings Inc | Steven Sherman | Director, CEO & Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2022 | 15,599 | 109,195 | - | - | Restricted Stock Units | |
| Ekso Bionics Holdings Inc | Steven Sherman | Director, CEO & Chairman | Sale of securities on an exchange or to another person at price $ 1.74 per share. | 21 Jun 2022 | 5,330 | 659,031 (0%) | 0% | 1.7 | 9,259 | Common Stock |
| Ekso Bionics Holdings Inc | Steven Sherman | Director, CEO & Chairman | Sale of securities on an exchange or to another person at price $ 1.76 per share. | 24 May 2022 | 6,597 | 637,408 (0%) | 0% | 1.8 | 11,605 | Common Stock |
| Ekso Bionics Holdings Inc | Steven Sherman | Director, CEO & Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2022 | 15,599 | 644,005 (0%) | 0% | 0 | Common Stock | |
| Ekso Bionics Holdings Inc | Steven Sherman | Director, CEO & Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2022 | 15,599 | 124,794 | - | - | Restricted Stock Units | |
| Ekso Bionics Holdings Inc | Steven Sherman | Director, CEO & Chairman | Sale of securities on an exchange or to another person at price $ 2.41 per share. | 28 Apr 2022 | 6,862 | 628,406 (0%) | 0% | 2.4 | 16,521 | Common Stock |
| Ekso Bionics Holdings Inc | Steven Sherman | Director, CEO & Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2022 | 15,599 | 140,393 | - | - | Restricted Stock Units | |
| Ekso Bionics Holdings Inc | Steven Sherman | Director, CEO & Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2022 | 15,599 | 635,268 (0%) | 0% | 0 | Common Stock | |
| Ekso Bionics Holdings Inc | Steven Sherman | Director, CEO & Chairman | Sale of securities on an exchange or to another person at price $ 2.94 per share. | 24 Mar 2022 | 6,389 | 619,669 (0%) | 0% | 2.9 | 18,784 | Common Stock |
| Ekso Bionics Holdings Inc | Steven Sherman | Director, CEO & Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2022 | 15,599 | 626,058 (0%) | 0% | 0 | Common Stock | |
| Ekso Bionics Holdings Inc | Steven Sherman | Director, CEO & Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2022 | 15,599 | 155,992 | - | - | Restricted Stock Units | |
| Ekso Bionics Holdings Inc | Steven Sherman | Director, CEO & Chairman | Sale of securities on an exchange or to another person at price $ 2.60 per share. | 15 Mar 2022 | 5,965 | 610,459 (0%) | 0% | 2.6 | 15,508 | Common Stock |
| Ekso Bionics Holdings Inc | Steven Sherman | Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2022 | 15,599 | 171,591 | - | - | Restricted Stock Units | |
| Ekso Bionics Holdings Inc | Steven Sherman | Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2022 | 15,599 | 55,564 (0%) | 0% | 0 | Common Stock |